Drug Profile
Erdosteine - Rafifarm
Latest Information Update: 27 Sep 2023
Price :
$50
*
At a glance
- Originator RAFIFARM
- Class Anti-inflammatories; Antibronchitics; Expectorants; Small molecules; Thioglycolates; Thiophenes
- Mechanism of Action Antioxidants; Glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Poisoning
Most Recent Events
- 27 Sep 2023 Discontinued - Preclinical for Poisoning in Romania (unspecified route)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Poisoning in Romania